1887

Abstract

Summary

Prednisolone, given orally or intraperitoneally before challenge, protected mice against the lethal effect of a crude cell extract of containing heat-labile toxin (HLT) as the major toxic component. Prednisolone did not diminish the lethal toxicity of heated cell suspensions containing pertussis toxin and endotoxin but devoid of HLT. This suggests that the protective effect of the steroid was directed against the HLT. When live bacteria were injected intraperitoneally, prednisolone showed a protective effect against the initial toxaemia. By day 7, however, the protection was no longer evident and the steroid promoted the survival of the organisms within the peritoneal cavity. These findings are discussed in the light of reports of the beneficial effects of corticosteroids in the treatment of whooping cough and in relation to a possible role for HLT in the pathogenesis of the disease.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-19-3-391
1985-06-01
2024-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/19/3/medmicro-19-3-391.html?itemId=/content/journal/jmm/10.1099/00222615-19-3-391&mimeType=html&fmt=ahah

References

  1. Barrie H. 1982; Treatment of whooping cough. Lancet 2:830–831
    [Google Scholar]
  2. Baxter J D, Rousseau G G. 1979; Glucocorticoid hormone action: an overview. Monographs on Endocrinology 12:1–24
    [Google Scholar]
  3. Dayal R S, Atal P R, Kumar Y. 1969; A comparative study of different culture techniques and therapeutic efficacy of newer antibiotics in pertussis. Indian Journal of Medical Sciences 23:421–427
    [Google Scholar]
  4. Dianese G. 1982; Treatment of whooping cough. Lancet 2:1224
    [Google Scholar]
  5. Fauci A S. 1979; Immunosuppressive and anti-inflammatory effects of glucocorticoids. Monographs on Endocrinology 12:449–465
    [Google Scholar]
  6. Finney D J. 1964 Statistical method in biological assay, 2. Griffin; London:
    [Google Scholar]
  7. Finney D J, Latscha R, Bennett B M, Hsu P. 1963; Tables for testing significance in a 2 × 2 contingency table. Cambridge University Press;
    [Google Scholar]
  8. Herbert D, Phipps P J, Strange R E. 1971; Chemical analysis of microbial cells. Norris J R, Ribbons D W. Methods in microbiology5B Academic Press; London:209–344
    [Google Scholar]
  9. Idigbe E O, Parton R, Wardlaw A C. 1981; Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium. Journal of Medical Microbiology 14:409–418
    [Google Scholar]
  10. Iida T, Kunitani A, Komase Y, Yamamoto A. 1963; Studies on experimental infection with Bordetella pertussis Effects of cortisone on the infection and immunity in mice. Japanese Journal of Experimental Medicine 33:283–295
    [Google Scholar]
  11. Ishida S. 1968; Characterization of the body weight-decreasing toxicities in mice by the lymphocytosis-promoting factor and the heat-labile toxin of B. pertussis and endotoxin. Japanese Journal of Medical Science and Biology 21:115–135
    [Google Scholar]
  12. Kass E H, Finland M. 1958; Corticosteroids and infections. Advances in Internal Medicine 9:45–80
    [Google Scholar]
  13. Kind L S. 1953; Inhibition of histamine death in pertussis inoculated mice by cortisone and neoantergan. Journal of Allergy 24:52–59
    [Google Scholar]
  14. Miller C L, Fletcher W B. 1976; Severity of notified whooping cough. British Medical Journal 1:117–119
    [Google Scholar]
  15. Munoz J. 1971; Protein toxins from Bordetella pertussis. Kadis S, Montie T C, Ajl S J. Microbial toxins IIa Bacterial protein toxins Academic Press; New York:271–300
    [Google Scholar]
  16. Olson L C. 1975; Pertussis. Medicine 54:427–469
    [Google Scholar]
  17. Perkins F T, Sheffield F W, Outschoorn A S, Hemsley D A. 1973; An international collaborative study on the measurement of the opacity of bacterial suspensions. Journal of Biological Standardization 1:1–10
    [Google Scholar]
  18. Pittman M. 1970; Bordetella pertussis: Bacterial and host factors in the pathogenesis and prevention of whooping cough. Mudd S. Infectious agents and host reactions W B Saunders Co; Philadelphia:239–270
    [Google Scholar]
  19. Pittman M. 1979; Pertussis toxin: The cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Reviews of Infectious Diseases 1:401–412
    [Google Scholar]
  20. Sultzer B M. 1972; Genetic control of host responses to endotoxin. Infection and Immunity 5:107–113
    [Google Scholar]
  21. Thompson H, McCandlish I A P, Wright N G. 1976; Experimental respiratory disease in dogs due to Bordetella bronchiseptica. Research in Veterinary Science 20:16–23
    [Google Scholar]
  22. Wardlaw A C, Parton R. 1982; Bordetella pertussis toxins. Pharmacology and Therapeutics 19:1–53
    [Google Scholar]
  23. Wardlaw A C, Parton R. 1983; Pertussis vaccine. Easmon C S F, Jeljaszewicz J. Medical microbiology 2 Immunization against bacterial disease Academic Press; London:207–253
    [Google Scholar]
  24. Wardlaw A C, Parton R, Hooker M J. 1976; Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. Journal of Medical Microbiology 9:89–100
    [Google Scholar]
  25. Zoumboulakis D, Anagnostakis D, Albanis V, Matsaniotis N. 1973; Steroids in treatment of pertussis: a controlled clinical trial. Archives of Disease in Childhood 48:51–54
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-19-3-391
Loading
/content/journal/jmm/10.1099/00222615-19-3-391
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error